{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "NCT04522505",
            "NStudiesAvail": 430108,
            "NStudiesFound": 1,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 1,
            "FieldList": [
                  "ResultsFirstSubmitDate",
                  "ResultsFirstSubmitQCDate",
                  "RetractionPMID",
                  "RetractionSource",
                  "SamplingMethod",
                  "SecondaryId",
                  "SecondaryIdDomain",
                  "SecondaryIdLink",
                  "SecondaryIdType",
                  "SecondaryOutcomeDescription",
                  "SecondaryOutcomeMeasure",
                  "SecondaryOutcomeTimeFrame",
                  "SeeAlsoLinkLabel",
                  "SeeAlsoLinkURL",
                  "SeriousEventAssessmentType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "ResultsFirstSubmitDate": [],
                        "ResultsFirstSubmitQCDate": [],
                        "RetractionPMID": [],
                        "RetractionSource": [],
                        "SamplingMethod": [
                              "Non-Probability Sample"
                        ],
                        "SecondaryId": [],
                        "SecondaryIdDomain": [],
                        "SecondaryIdLink": [],
                        "SecondaryIdType": [],
                        "SecondaryOutcomeDescription": [
                              "Evaluate disease activity of 9 organ systems and display it as a score. The score is weighted from 1 to 8 at each system, if descriptor is present at the time of visit or in the proceeding 10 days.\n\nChange in SLEDAI>3 points means mild or moderate flare\nChange in SLEDAI>12 points means severe flare",
                              "The change in disease activity in the last 4 weeks compared to the previous 4 weeks is evaluated as score.",
                              "Only if the damage due to the disease lasted for at least 6 months is evaluated on a scale 0-47.",
                              "Investigator evaluated disease activity in mm using 0 to 100mm visual analogue scale (VAS). High score indicates worsening of the disease."
                        ],
                        "SecondaryOutcomeMeasure": [
                              "SLEDAI-2K (Systemic Lupus Erythematosus Disease Activity Index-2000)",
                              "BILAG 2004 (British Isles Lupus Assessment Group 2004)",
                              "SDI (Systemic Lupus International Collaborating Clinics/Americans College of Rheumatology (SLICC/ACR) Damage Index",
                              "Disease activity assessed by PGA (Physician Global Assessment)"
                        ],
                        "SecondaryOutcomeTimeFrame": [
                              "up to 57 months after enrollment",
                              "up to 57 months after enrollment",
                              "up to 57 months after enrollment",
                              "up to 57 months after enrollment"
                        ],
                        "SeeAlsoLinkLabel": [],
                        "SeeAlsoLinkURL": [],
                        "SeriousEventAssessmentType": [],
                        "NCTId": [
                              "NCT04522505"
                        ]
                  }
            ]
      }
}